Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recruiting × Hepatectomy × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 127 Carcinoma, Non-Small-Cell Lung 102 Prostatic Neoplasms 65 Colorectal Neoplasms 52 Nasopharyngeal Carcinoma 46 Neoplasms 43 Multiple Myeloma 38 Stomach Neoplasms 34 Lung Neoplasms 33 Leukemia, Myeloid, Acute 31 Ovarian Neoplasms 30 Neoplasm Metastasis 30 Carcinoma, Hepatocellular 28 Squamous Cell Carcinoma of Head and Neck 25 Recurrence 25 Pancreatic Neoplasms 25 Triple Negative Breast Neoplasms 24 Rectal Neoplasms 23 Small Cell Lung Carcinoma 22 Uterine Cervical Neoplasms 21 Colonic Neoplasms 21 Brain Neoplasms 21 Esophageal Neoplasms 20 Urinary Bladder Neoplasms 16 Lymphoma, Large B-Cell, Diffuse 16 Myasthenia Gravis 15 Melanoma 15 Lymphoma, Follicular 15 Head and Neck Neoplasms 15 Endometrial Neoplasms 15

Interventions

Methylprednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07507643 2026-04-02

A Study of Methylprednisolone in People Having Liver Surgery

Memorial Sloan Kettering Cancer Center

Phase 3 Recruiting

Hepatectomy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡